retatrutide clinical trials safety retatrutide profile A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Phase III retatrutide study demonstrates
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

























